Revere Pharmaceuticals
PrivateLast Round
M&A
Feb 22, 2021
Total Funding Raised
$3.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Revere Pharmaceuticals is a biotechnology company developing small molecule therapeutics targeting Rho GTPase proteins for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revere Pharmaceuticals Comparables
Compare Revere Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MBQ Pharma | 87% | |
| SHY Therapeutics | 73% | |
| Revolution Medicines | 67% | |
Revere Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Feb 22, 2021 | ||||
| Seed | Jun 22, 2020 |
Revere Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XLerateHealth | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 49% MoM, reaching 1.4K.
- Feb 2, 2026
Monthly visitors grew 686% MoM, reaching 904.
Revere Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Revere Pharmaceuticals's valuation, stock price, and market status.